This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Johns Hopkins University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Nathachit Limjunyawong: Innovator in Chronic Itch Treatment
Introduction: Nathachit Limjunyawong is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic itch conditions. His innovative approach focuses on the use of small molecule MrgprX4 antagonists.
Latest Patents: Limjunyawong holds a patent for a method that treats chronic itch conditions by administering small molecule MrgprX4 antagonists. This invention relates to cells and methods for detecting compounds that affect G protein-coupled receptor-mediated conditions. Additionally, it addresses methods for treating adverse drug reactions, autoimmune disorders, and pruritus.
Career Highlights: Limjunyawong is affiliated with The Johns Hopkins University, where he continues to advance research in his field. His work has garnered attention for its potential to improve the quality of life for individuals suffering from chronic itch and related conditions.
Collaborations: Some of his notable coworkers include Xinzhong Dong and Chirag Vasavda, who contribute to the collaborative research efforts at The Johns Hopkins University.
Conclusion: Nathachit Limjunyawong's innovative work in treating chronic itch conditions showcases the importance of research and development in medicine. His contributions are paving the way for new therapeutic approaches that could benefit many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile